{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Goulart AC"],"funding":["National Institute for Health Research (NIHR)","National Institute for Health and Care Research"],"pagination":["e0292463"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10569511"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["18(10)"],"pubmed_abstract":["<h4>Background</h4>Atrial fibrillation (AF) is a major risk factor for stroke. To enable improvements to AF diagnosis and follow-up care, understanding current patient pathways and barriers to optimal care are essential. We investigated the patient care pathways and their drivers, and the impact of the COVID-19 pandemic on patient pathways in a middle-income country setting, Brazil.<h4>Methods</h4>This mixed-methods study in São Paulo, included adults (≥18y) with AF from 13 primary/secondary healthcare facilities. Surveys using baseline, follow-up (administered ≥two months after baseline) and COVID-19 questionnaires (quantitative), and three focus group discussions (FGDs) were conducted. Minimum sample size for the quantitative component was 236 and we aimed to reach saturation with at lea"],"journal":["PloS one"],"pubmed_title":["Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study."],"pmcid":["PMC10569511"],"funding_grant_id":["17/63/121"],"pubmed_authors":["Varella AC","Olmos RD","Jolly K","Goulart AC","Lip GYH","Lotufo PA","Bensenor IM","Greenfield S","Gooden TE","Thomas GN","Manaseki-Holland S","NIHR Global Health Research Group on Atrial Fibrillation Management"],"additional_accession":[]},"is_claimable":false,"name":"Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.","description":"<h4>Background</h4>Atrial fibrillation (AF) is a major risk factor for stroke. To enable improvements to AF diagnosis and follow-up care, understanding current patient pathways and barriers to optimal care are essential. We investigated the patient care pathways and their drivers, and the impact of the COVID-19 pandemic on patient pathways in a middle-income country setting, Brazil.<h4>Methods</h4>This mixed-methods study in São Paulo, included adults (≥18y) with AF from 13 primary/secondary healthcare facilities. Surveys using baseline, follow-up (administered ≥two months after baseline) and COVID-19 questionnaires (quantitative), and three focus group discussions (FGDs) were conducted. Minimum sample size for the quantitative component was 236 and we aimed to reach saturation with at lea","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2026-06-01T08:42:35.753Z","creation":"2024-10-19T05:47:50.327Z"},"accession":"S-EPMC10569511","cross_references":{"pubmed":["37824516"],"doi":["10.1371/journal.pone.0292463"]}}